Navigation Links
Perrigo Confirms Filing For Generic Version Of Acanya
Date:11/20/2013

ALLEGAN, Mich., Nov. 20, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% and has notified Dow Pharmasciences, the owner of the New Drug Application (NDA) of its filing.

(Logo:  http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

On November 15, 2013, Dow Pharmasciences and Valeant Pharmaceuticals filed suit against Perrigo in the United States District Court for the District of New Jersey, alleging patent infringement. This action formally initiates the process under the Hatch-Waxman Act. 

Acanya® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Annual sales were approximately $122 million annually, as measured by Symphony Health Solutions.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This filing is another example of our investment in extended topical product development. As always, Perrigo is committed to making quality healthcare more affordable for our customers."                  

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store b
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
2. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
3. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
4. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
5. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
6. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
7. Perrigo Company To Present At The William Blair Growth Stock Conference
8. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
9. Perrigo Company Announces Quarterly Dividend
10. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
11. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 Amgen (NASDAQ: AMGN ) today ... Key results include: , Total revenues increased 11 ... million, with 12 percent product sales growth driven primarily ... EPOGEN ® (epoetin alfa), Sensipar ® (cinacalcet) ... exchange rates impacted total revenue and product sales growth ...
(Date:4/21/2015)... 2015  Inmark,s acquisition of Saf-T-Pak last week ... Training, specifically Division 6.2.  For over 25 years, ... programs focusing on IATA, ICAO, US DOT, Transport ... "We were particularly interested in Saf-T-Pak,s proprietary ... internet training programs," said David Oyler , ...
(Date:4/21/2015)... , April 21, 2015 The global dermatology ... CAGR of 8.2% from 2014 to 2019. ... hold larger shares in the global dermatology diagnostic ... devices market is mainly attributed to a wide range ... growing demand of dermatologists, and technological advancements made in ...
Breaking Medicine Technology:Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 2Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 3Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 4Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 5Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 6Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 7Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 8Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 9Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 10Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 11Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 12Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 13Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 14Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 15Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 16Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 17Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 18Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 19Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3
... MELVILLE, N.Y. , July 19 Nycomed US Inc. today ... Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing ... commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and ... , ...
... announces that a new market research report is available in its catalogue: , ... Global Pharma-biotech Alliance Analysis , ... , , , ... deals struck from 2008 to present. This study covers deal structures by therapeutic area, stage ...
Cached Medicine Technology:Steve Andrzejewski Joins Nycomed US Inc. 2Reportlinker Adds Global Pharma-biotech Alliance Analysis 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 The Alzheimer’s ... partnership with JustSayCheese.com, a Colorado business that turns personal ... According to Larry Barrett, Vice President of Sales for ... in the fact that many of us have personal ... dedicated to working hard to support the Association’s efforts. ...
(Date:4/21/2015)... 21, 2015 Grafika is pleased to ... Offset Impressions. , “We’re excited about the ... printing capabilities and knowledgeable team members,” according to Bernard ... us to offer an ever wider breadth of products ... and specialty services we already offer. It also ...
(Date:4/21/2015)... “ ZeroWire ” was featured on ... takes a look at the latest and coolest technology ... special reporter for NewsWatch and a technology expert, conducted ... a security system and lifestyle management hub. , According ... 2 million burglaries in 2010. It goes without saying ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... AvePoint, the established leader in ... a new enhancement to DocAve Policy Enforcer ... Management Activity API. This integration creates a new information ... action on all events that take place throughout their ... Activity API provides customers with greater transparency and insight ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3
... Using insect repellent in addition to insecticide treated bednets (ITNs) ... areas where mosquitoes feed in the early evening. , The ... at the London School of Hygiene & Tropical Medicine and ... at the Ministry of Health in La Paz, Bolivia, are ...
... Nov. 12 What does a,thirty-nine foot Airstream Land ... For more than 800 midlands, men last month, it ... for the disease. The Drive Against Prostate Cancer ... prostate cancer. Doctors Care and WIS-TV,sponsored The Drive in ...
... China Pharma,Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) ... at 11:00 a.m. EST on Thursday,November, 15, 2007, to ... Joining Ms. Zhilin Li, President and CEO of China ... Company plans to release its,earnings earlier that same day. ...
... Nov. 12 SpaCapsule(R),( http://www.spacapsule.com ), the most advanced ... one sleek, space-age,machine, has retained one of Florida,s ... quickest de-stressing and relaxation experience on,the planet. ... machine that in a matter,of minutes can take ...
... Rose 12.8% to US$14.3 Million (RMB 107.7 ... Million) Compared to Third Quarter 2006, BEIJING, ... FFHL ), a manufacturer and distributor of,high-quality BOPET plastic film ... quarter and for the nine months,ended September 30, 2007 which ...
... Global Landmarks Mark First United Nations World Diabetes Day ... up in blue to mark the,first United Nations-observed World ... most iconic buildings and sites. The landmarks will,light up ... circle, the global,symbol for diabetes. The Empire State ...
Cached Medicine News:Health News:Repellents between dusk and bedtime make insecticide-treated bednets more effective 2Health News:UCI Medical Affiliates, Inc. Sponsors Doctors Care Record-breaking Drive Against Prostate Cancer 2Health News:China Pharma Holdings, Inc. Announces Conference Call to Discuss Third Quarter 2007 Results 2Health News:The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR 2Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 2Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 3Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 4Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 5Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 6Health News:World Diabetes Day Lights Up the Skyline 2Health News:World Diabetes Day Lights Up the Skyline 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: